Abstract
The COVID-19 pandemic disproportionately disrupts the daily lives of marginalized populations. Persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs. They face significant harm from both the pandemic itself and its social and economic consequences, including marginalization in health care and social systems. Hence, we discuss: (1) why persons with substance use disorders are at increased risk for infection with COVID-19 and a severe illness course; (2) anticipated adverse consequences of COVID-19 in persons with substance use disorders; (3) challenges to health care delivery and substance use treatment programs during and after the COVID-19 pandemic; and (4) the potential impact on clinical research in substance use disorders. We offer recommendations for clinical, public health, and social policies to mitigate these challenges and to prevent negative outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 286-291 |
| Number of pages | 6 |
| Journal | Substance Abuse |
| Volume | 41 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2 Jul 2020 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 1 No Poverty
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- addiction
- alcohol
- cannabis
- clinical care
- clinical research
- cocaine
- opioids
- pandemic
- substance use disorders
- tobacco
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'COVID-19 and persons with substance use disorders: Inequities and mitigation strategies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver